Company News
Friday, April 28, 2017
BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package
* Says U.S. wholesale acquisition cost of Rydapt for AML
indication is $7,495 for 14-day package and $14,990 for 28-day
package - spokeswoman
Further company coverage:
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment